Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Tumori|March 9, 2022
Paraneoplastic neurological syndromes in patients affected by SCLC: a case seriesCaterina Zanella, Alberto Giovanni Leone, Luca Zambelli, et al.
Case Reports in Oncology|October 11, 2016
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-UpClaudio Vernieri, Daniela Femia, Sara Pusceddu, et al.
Journal of Medical Case Reports|July 21, 2012
Subcutaneous metastases from colon cancer: a case reportGiuseppe Lo Russo, Fabio Accarpio, Gian Paolo Spinelli, et al.
Oncotarget|September 24, 2017
Concomitant <i>EML4-ALK</i> rearrangement and <i>EGFR</i> mutation in non-small cell lung cancer patients: a literature review of 100 casesGiuseppe Lo Russo, Martina Imbimbo, Giulia Corrao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2014
Correlation between fertility drugs use and malignant melanoma incidence: the state of the artFederica Tomao, Anselmo Papa, Giuseppe Lo Russo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature reviewGiulia Galli, Giulia Corrao, Martina Imbimbo, et al.
Expert Review of Anticancer Therapy|June 30, 2016
Update on medical treatment of small intestinal neuroendocrine tumorsSara Pusceddu, Daniela Femia, Giuseppe Lo Russo, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Trustworthy assessment of 2D model for lung CT scansMargherita Favali, Vanja Miskovic, Alberto Eusebio, et al.
Current Cancer Drug Targets|July 27, 2012
Chemotherapy and target therapy in the management of adult high- grade gliomasGian Paolo Spinelli, Evelina Miele, Giuseppe Lo Russo, et al.
Therapeutics and Clinical Risk Management|November 21, 2013
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot studyLuigi Rossi, Federica Tomao, Giuseppe Lo Russo, et al.
Pageof 14